Mangaluru: Over 60 donate hair at ‘Locks of Love’ hair donation drive

Udupi, Jun 28: The Padubidri police have booked cases against two patients of Novel Coronavirus for not revealing their primary contacts and hiding their travel history.

According to DHO Sudhirchandra Sooda, two siblings from Hejamadi in Padubidri had tested positive for COVID-19 recently. After shifting to the hospital, when the officials asked them about their primary contacts and travel history, the patients furnished false information.

When the officials collected information from various sources, they realised that the duo had travelled to Bantwal, Kasargod, Ullal and other places in Dakshina Kannada, said Dr Sooda. Hence, the district administration decided to file cases against them, he added.

Bengaluru, Mar 6: At least 13 persons, including women and children, were killed and five critically wounded when an SUV collided with a car that had crashed against a road divider moments ago near Kunigal in Tumakuru district of Karnataka in the early hours of Friday, police said.

Of the victims, while 12 died on the spot, a child breathed his last in a hospital, they added.

The injured were admitted to the hospital, the police said.

Among the dead, 10 were from Tamil Nadu and three from Bengaluru. All of them were pilgrims who were on their way to Dharmasthala in Karnataka.

There were five women and two children among the dead, the police said.

"Thirteen persons have died. The incident occurred post midnight. A car crashed against the road divider and another car collided with it," Tumakuru Superintendent of Police (SP) K Vamsi Krishna said.

The police had to struggle to pull the bodies out from the mangled vehicles.

On learning about the incident, relatives of the victims rushed to the spot.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.